Research

Research Profiles    |    Publications    |    Clinical Trials

Publications

2025

Bleeding

Supportive care for amyloidosis: International Society of Amyloidosis expert panel guidelines. Amyloid 2025;32:93-116.

Automated von Willebrand factor multimer image analysis for improved diagnosis and classification of von Willebrand disease. Int J Lab Hematol 2025 Online ahead of print.

Thrombosis

Incidence, risk factors, and outcomes of patients with monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia  who develop venous thromboembolism. J Thromb Haemost 2025;23:149-157.

Topography of ischemic strokes in cancer-associated non-bacterial thrombotic endocarditis: a single institution descriptive case series. J Stroke Cerebrovasc Dis 2025;34:108171.

Thrombotic Microangiopathy

Relapsed-free survival is progressively shortened in a subset of Black patients in immune-mediated thrombotic thrombocytopenic purpura treated in the rituximab era. Blood Adv 2025;9:417-424.

Clinical outcomes and treatment strategies of adult transplant-associated thrombotic microangiopathy: external validation of harmonizing definitions and high-risk criteria. Am J Hematol 2025;100:830-839.

Evaluating the potential for iodinated radiocontrast agents to interfere with ADAMTS13 activity testing via fluorescence resonance energy transfer methodology. Am J Clin Pathol 2025;163:610-617.

Cytopenias/Cytosis

Practical anemia bundle and hemoglobin recovery in critical illness: a randomized clinical trial. JAMA Open Netw 2025;8:e252353.

Design and staged implementation of a multidisciplinary preoperative anemia clinic at a tertiary medical center. Anesth Analg 2025 Online ahead of print.

Acute kidney injury: an underrecognized feature of VEXAS syndrome. Rheum 2025;64:2027-2033.

Blood transfusions in the emergency department: a descriptive analysis and referral patterns at a non-trauma center. Am J Emerg Med 2025;94:153-157.

Variation in complete blood count reports across US hospitals. JAMA Open Netw 2025;8:e2514050.

2024

Bleeding

A brief history of hemostasis and thrombosis at the Mayo Clinic. Semin Thromb hemost 2024;50:26-33.

International council for standardization in haematology recommendations on fibrinogen assays, thrombin clotting time and related tests in the investigation of bleeding disorders. Int J Lab Hematol 2024;46:20-32.

Use of crushed tranexamic acid tablets in water for paediatric patients with bleeding disorders. Haemophilia 2024;30:648-657.

Transplacental transfer of emicizumab: experience with emicizumab in a pregnant female with severe hemophilia A and an inhibitor. Haemophilia 2024;30:868-871.

The clinical impact of acquired von Willebrand syndrome secondary to Waldenstrom macroglobulinemia: an underrecognized source of major bleeding events. Leukemia 2024;38:2497-2500.

Improving patient safety through proper ordering and administration of andexanet alfa. Mayo Clin Proc Innov Qual Outcomes 2024;8:407-414.

Thrombosis

Effect of residual platelets in frozen-thawed plasma on results of dilute Russell’s viper venom time assay for lupus anticoagulant testing. Am J Clin Pathol 2024;161:212-215.

COVID-19 infection and risk stratification for pulmonary embolism: identifying optimal D-dimer thresholds. Thromb Res 2024;235:8-10.

The lupus anticoagulant titer is associated with elevated antiphosphatidylserine/prothrombin immunoglobulin-M isotype antibody levels. Int J Lab Hematol 2024;46:695-704.

Extending venous thromboembolism secondary prevention with apixaban in cancer patients. The EVE trial. J Thromb Haemost 2024;22:1704-1714.

Echocardiographic findings in cancer-associated non-bacterial thrombotic endocarditis: Clinical series of 111 patients from a single institution. Eur Heart J Cardiovasc Imaging 2024;26:1255-1263.

Cancer-associated non-bacterial thrombotic endocarditis – clinical series from a single institution. Am J Hematol 2024;99:596-605.

Inherited thrombophilia and recurrent miscarriage: is there a role for anticoagulation during pregnancy? Hematology Am Soc Hematol Educ Program 2024;2024:672-677.

Thrombotic Microangiopathy

A descriptive analysis of fatal outcomes in immune thrombotic thrombocytopenic purpura in the USTMA TTP Registry. Blood Adv 2024;8:620-623.

A machine learning approach to predict mortality due to immune-mediated thrombotic thrombocytopenic purpura. Res Pract Thromb Haemost 2024;8:102388.

Relapse-free survival is progressively shortened in a subset of Black patients with immune-mediated TTP treated in the rituximab era. Blood Adv 2025;9:417-424.

VEXAS Syndrome

Venous and arterial thrombosis in patients with VEXAS syndrome. Blood 2024;143:2190-2200.

Comprehensive morphologic characterization of bone marrow biopsy findings in a large cohort of patients with VEXAS syndrome: a single institution longitudinal study of 111 bone marrow samples from 52 patients. Am J Clin Pathol 2024;161:609-624.

Acute kidney injury, an underrecognized feature of VEXAS syndrome. Rheumatology 2025;64:2027-2033.

Vasculitis associated with VEXAS syndrome. Rheumatology 2025;64:3889-3894.

Cytopenias/Cytosis

C3+ and C3- warm autoimmune hemolytic anemias: a comparison of clinical characteristics and treatment outcomes. Eur J Haematol 2024;113:132-134.

Paroxysmal nocturnal hemoglobinuria: review of the patient experience and treatment landscape. Blood Rev 2024;64:101158.

Impact of thrombocytopenia on survival in patients with hepatocellular carcinoma: updated meta-analysis and systematic review. Cancers 2024;16:1293.

Elderly male with Epstein-Barr virus-induced pure red cell aplasia. Cureus 2024;16:e61970.

A comprehensive review on gelatinous transformation of the bone marrow. Expert Rev Hematol 2024;17:547-554.

Clinical outcomes of lung transplant recipients with myelodysplastic syndrome and short telomere syndrome – case series. Transplant Proc 2024;56:2237-2241.

BCR-ABL testing in the evaluation of neutrophilia. Am J Hematol 2024;99:1651-1654.